News-Medical.Net on MSN
Targeting IDO1 for cancer: Novel degraders show promise in preclinical studies
Cancer cells employ a variety of strategies to evade the immune system, and modern immunotherapies aim precisely at these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback